Heart Disease and COVID-19
COVID-19 is a "Perfect Storm for Heart Health" according to the World Heart Federation. 1. Individuals with COVID-19 and heart disease are at the highest risk of death and severe [...]
COVID-19 is a "Perfect Storm for Heart Health" according to the World Heart Federation. 1. Individuals with COVID-19 and heart disease are at the highest risk of death and severe [...]
CARDIAC DISEASE AND GENETIC FACTORS Genes are what make you similar to your relatives. Problems (pathogenic mutations) in genes can cause your family members to be at risk for a [...]
Hereditary Cardiovascular Risk Assessment is the Most Effective Way of Identifying At-Risk Individuals or Confirming a Diagnosis of Existing Cardiac Conditions. It Opens the Door for More Precise and Individualized [...]
Genetic Testing of Fetal Cell Free DNA - No Risk to Pregnancy (in Contrast with Amniocentesis) Fetal Cell Free DNA is present in subtle amounts in the bloodstream from as [...]
Advanced Solution for Targeted Next Generation Sequencing (NGS) of Circulating Cell-Free Tumor DNA. ctDNA (Circulating Tumor DNA) consist of only a small fraction of cfDNA (Cell Free DNA). ctDNA mutations [...]
Quantity and Quality of DNA are Similar to Blood Methods! Ayass BioScience, LLC now accepts mouthwash as a collection method for genomic DNA for our Pharmacogenetic Testing. This method is [...]
SCREENING AND EARLY CANCER DETECTION • REAL TIME MONITORING OF CANCER THERAPY Dying cancer cells shed very small amount of DNA into blood. Gene-sequencing machines decode millions of short fragments [...]
The Mitochondrial genome is extremely small when compared to the nuclear genome, and mitochondrial DNA (mtDNA) mutations are complex and difficult to trace, but they play an important role in [...]
Cytochrome P450 (CYP450) tests help determine how your body processes (metabolizes) or responds to medications. We look for variations in cytochrome P450 genes that can affect the breakdown of medications. Depending [...]
The Proteomics studies that corroborate Metabolomics findings are the next generation of laboratory testing using the Mass Spectrometry, a key technology for targeted protein and metabolite identification and quantification. This assay [...]
At Ayass BioScience, we use high-throughput Next Generation Sequencing technology to sequence cancer patients' solid tumor DNA (Breast cancer, Lung cancer, Colorectal cancer, Prostate cancer, Cervical cancer). Targeted sequencing of tumor DNA across our [...]